company background image
867 logo

China Medical System Holdings SEHK:867 Stock Report

Last Price

HK$7.07

Market Cap

HK$17.2b

7D

-3.7%

1Y

-45.5%

Updated

17 Jun, 2024

Data

Company Financials +

China Medical System Holdings Limited

SEHK:867 Stock Report

Market Cap: HK$17.2b

867 Stock Overview

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

867 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth2/6
Past Performance2/6
Financial Health6/6
Dividends4/6

China Medical System Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Medical System Holdings
Historical stock prices
Current Share PriceHK$7.07
52 Week HighHK$15.86
52 Week LowHK$6.51
Beta0.82
1 Month Change-1.53%
3 Month Change-41.57%
1 Year Change-45.53%
3 Year Change-65.09%
5 Year Change5.68%
Change since IPO135.04%

Recent News & Updates

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

May 22
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

May 03
China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Recent updates

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

May 22
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

May 03
China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

May 02
We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 19
China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Mar 29
China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

Mar 28
Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

Dec 21
China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

Is China Medical System Holdings (HKG:867) A Risky Investment?

Dec 04
Is China Medical System Holdings (HKG:867) A Risky Investment?

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Nov 15
If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

Aug 31
China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Aug 30
China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

Aug 07
Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

May 14
We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Apr 26
Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

Feb 05
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

Dec 26
China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Dec 08
If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Sep 14
Is China Medical System Holdings (HKG:867) Using Too Much Debt?

China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

Aug 25
China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

Aug 15
Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Jul 08
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

May 16
Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Apr 10
Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

Mar 22
China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Feb 09
If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Dec 25
Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Nov 10
Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Sep 25
China Medical System Holdings (HKG:867) Could Easily Take On More Debt

China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

Aug 26
China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching

Jul 30
Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued

Jun 27
An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Jun 14
China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Apr 20
Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Is There An Opportunity With China Medical System Holdings Limited's (HKG:867) 43% Undervaluation?

Mar 25
Is There An Opportunity With China Medical System Holdings Limited's (HKG:867) 43% Undervaluation?

Shareholders Are Loving China Medical System Holdings Limited's (HKG:867) 3.0% Yield

Mar 08
Shareholders Are Loving China Medical System Holdings Limited's (HKG:867) 3.0% Yield

Here's What China Medical System Holdings Limited's (HKG:867) Shareholder Ownership Structure Looks Like

Feb 09
Here's What China Medical System Holdings Limited's (HKG:867) Shareholder Ownership Structure Looks Like

Shareholder Returns

867HK PharmaceuticalsHK Market
7D-3.7%-1.8%-1.8%
1Y-45.5%-6.8%-3.7%

Return vs Industry: 867 underperformed the Hong Kong Pharmaceuticals industry which returned -6.8% over the past year.

Return vs Market: 867 underperformed the Hong Kong Market which returned -3.7% over the past year.

Price Volatility

Is 867's price volatile compared to industry and market?
867 volatility
867 Average Weekly Movement11.2%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 867's share price has been volatile over the past 3 months.

Volatility Over Time: 867's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
19955,701Kong Lamweb.cms.net.cn/zh/home/

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis. The company also offers Salofalk for treating Ulcerative Colitis and Crohn’s disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; ILUMETRI, a tildrakizumab injection to treat moderate-tosevere plaque psoriasis; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.

China Medical System Holdings Limited Fundamentals Summary

How do China Medical System Holdings's earnings and revenue compare to its market cap?
867 fundamental statistics
Market capHK$17.25b
Earnings (TTM)HK$2.58b
Revenue (TTM)HK$8.63b

6.7x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
867 income statement (TTM)
RevenueCN¥8.01b
Cost of RevenueCN¥1.94b
Gross ProfitCN¥6.08b
Other ExpensesCN¥3.68b
EarningsCN¥2.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.98
Gross Margin75.82%
Net Profit Margin29.96%
Debt/Equity Ratio8.3%

How did 867 perform over the long term?

See historical performance and comparison

Dividends

6.0%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.